Additionally, information on TBM treatment regimen, ART adherence, CD4 counts, and viral loads, as well as corticosteroid use and the presence of drug-resistant TB strains, were unavailable, potentially influencing our results. This evidence concerns the gene CD4 and tuberculosis.